Mutlu Doğan (Mutlu Dogan)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Locally Advanced

Neoadjuvant Chemotherapy

Ejection Fraction

Top Venues

Future oncology (London, England)

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Expert opinion on drug safety

Journal of chemotherapy (Florence, Italy)

This page only lists publications with an associated author ORCID identifier.

Publications

Cengiz Karaçin, Veli Sunar, Zuhat Urakci, Ali Yilmaz, Murat Ayhan, Mustafa Ersoy, Deniz Can Guven, Ismail Erturk, Yasin Durmus, Pinar Karacin, Nurettin Boran, Yaprak Engin Ustun, Mutlu Meydan, Mutlu Doğan, Berna Oksuzoğlu, Ozturk Ates, Mustafa Karaca, Dogan Uncu, Yakup Ergün, Zafer Arik
Efficacy and safety of bevacizumab in patients with low-grade serous ovarian cancer. Future oncology (London, England) 20 (4) (2024)
Cengiz Karaçin, Veli Sunar, Zuhat Urakci, Ali Yilmaz, Murat Ayhan, Mustafa Ersoy, Deniz Can Guven, Ismail Erturk, Yasin Durmus, Pinar Karacin, Nurettin Boran, Yaprak Engin Ustun, Mutlu Meydan, Mutlu Doğan, Berna Oksuzoğlu, Ozturk Ates, Mustafa Karaca, Dogan Uncu, Yakup Ergün, Zafer Arik
Efficacy and safety of bevacizumab in patients with low-grade serous ovarian cancer. Future oncology (London, England) (2024)
Cengiz Karaçin, Veli Sunar, Zuhat Urakci, Ali Yilmaz, Murat Ayhan, Mustafa Ersoy, Deniz Can Guven, Ismail Erturk, Yasin Durmus, Pinar Karacin, Nurettin Boran, Yaprak Engin Ustun, Mutlu Meydan, Mutlu Doğan, Berna Oksuzoğlu, Ozturk Ates, Mustafa Karaca, Dogan Uncu, Yakup Ergün, Zafer Arik
Efficacy and safety of bevacizumab in patients with low-grade serous ovarian cancer. Future oncology (London, England) 20 (4) (2024)
Alper Türkel, Mustafa Özdemir, Aziz Kurtuluş, Mutlu Doğan
Gemcitabine-associated digital necrosis in metastatic breast cancer. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)
Tugba Basoglu Tuylu, Abdullah Sakin, Cihan Erol, Ercan Özden, Devrim Çabuk, Ebru Çılbır, Deniz Tataroğlu Özyükseler, Murat Ayhan, Mehmet Ali Şendur, Mutlu Doğan, Berna Öksüzoğlu, Melek Karakurt Eryılmaz, Özlem Er, Elif Şenocak Taşçı, Neslihan Özyurt, Ozgecan Dulgar, Miraç Özen, İlhan Hacıbekiroğlu, İrem Öner, Esma Türkmen Bekmez, Hasan Cagrı Yıldırım, Şuayib Yalçın, Semra Paydaş, Emre Yekedüz, Asude Aksoy, Melike Özçelik, Abdilkerim Oyman, Elvina Almuradova, Bülent Karabulut, Nazan Demir, Murat Dinçer, Nuriye Özdemir, Dilek Erdem, Naziye Ak, Ali İnal, Derya Kıvrak Salim, Gülhan İpek Deniz, Teoman Şakalar, Ahmet Gülmez, Turgut Kaçan, Özlem Özdemir, Özkan Alan, Çağlar Ünal, Yusuf Karakaş, Serdar Turhal, Perran Fulden Yumuk
Real life experience of patients with locally advanced gastric and gastroesophageal junction adenocarcinoma treated with neoadjuvant chemotherapy: a Turkish oncology group study. Journal of chemotherapy (Florence, Italy) (2022)
Aykut Bahçeci, Semra Paydaş, Naziye Ak, Ferhat Ferhatoglu, Pınar Mualla Saip, Gülşah Seydaoğlu, Mehmet Bilici, Melih Şimşek, Salim Başol Tekin, Züleyha Çalikuşu, Sinan Yavuz, Ahmet Bilgehan Şahin, Erdem Cubukcu, Türkkan Evrensel, Serkan Degirmencioglu, Atike Gökçen Demiray, Perran Fulden Yumuk, Özkan Alan, Duygu İlke Çikman, Fuat Hulusi Demirelli, Osman Köstek, Ali Gökyer, Mutlu Doğan, Öznur Bal, Burcu Çakar, Erhan Gökmen, Deniz Yamaç, Taner Korkmaz, Altay Aliyev, Özge Keskin, Semiha Urvay, Mahmut Büyükşimşek, Cemile Karadeniz, Birol Yildiz, Havva Yeşil Çinkir, Hacer Demir, Ismail Beypinar, Cengiz Karaçin, Kadir Eser, Meltem Baykara, Saadettin Kılıçkap, Kerem Okutur, Gülcan Bulut, Ali Alkan, Erkan Arpaci, Kezban Nur Pilanci, Atakan Demir, Deniz Işik, Nilgün Yildirim
Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience. Cancer investigation 39 (6-7) (2021)
Yusuf Acikgoz, Öznur Bal, Gokhan Ucar, Ayse Durnali, Yakup Ergün, Merve Dirikoc, Selin Akturk Esen, Mutlu Doğan
Is there any clinical or laboratory predictive factor for cetuximab-induced skin toxicity? Expert opinion on drug safety 20 (5) (2021)
Mehmet Hadi Akkus, Omur Kaman, Mutlu Doğan
Alectinib continuation during COVID 19 'antiviral' treatment: Risk or benefit? Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 27 (5) (2021)
Cengiz Karaçin, Tulay Eren, Esra Zeynelgil, Goksen İnanc İmamoglu, Mustafa Altınbaş, Ibrahim Karadag, Fatma Bugdayci Basal, Hasan Selçuk Özger, Osman Sütçüoğlu, Ozan Yazıcı, Nuriye Ozdemir, Ahmet Özet, Yeşim Yıldız, Selin Aktürk Esen, Gokhan Ucar, Doğan Uncu, Bedia Dinc, Musa Baris Aykan, İsmail Ertürk, Nuri Karadurmus, Burak Civelek, İsmail Çelik, Yakup Ergün, Mutlu Doğan, Ömür Berna Çakmak Öksüzoğlu
Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy. Future oncology (London, England) 17 (33) (2021)
Serdar NazimTurhal, Mutlu Doğan, Guldal Esendagli, Mehmet Artac, Levent Korkmaz, Hasan Senol Coskun, Erdem Goker, Fulden PerranYumuk, Irem Bilgetekin, Fatih Kose, Dogan Uncu, Halil Kavgaci, Gulen Akyol, Ahmet Ozet, Tamer Yagci
The Relationship Between Plexin C1 Overexpression and Survival in Hepatocellular Carcinoma: a Turkish Oncology Group (TOG) Study. Journal of gastrointestinal cancer (2021)